Cargando…
A single mutation in the E2 glycoprotein of hepatitis C virus broadens the claudin specificity for its infection
Entry of the hepatitis C virus (HCV) into host cells is a multistep process mediated by several host factors, including a tight junction protein claudin-1 (CLDN1). We repeatedly passaged HCV-JFH1-tau, an HCV substrain with higher infectivity, on Huh7.5.1-8 cells. A multi-passaged HCV-JFH1-tau lot wa...
Autores principales: | Shirasago, Yoshitaka, Fukazawa, Hidesuke, Nagase, Shotaro, Shimizu, Yoshimi, Mizukami, Tomoharu, Wakita, Takaji, Suzuki, Tetsuro, Tani, Hideki, Kondoh, Masuo, Kuroda, Takuya, Yasuda, Satoshi, Sato, Yoji, Hanada, Kentaro, Fukasawa, Masayoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9691748/ https://www.ncbi.nlm.nih.gov/pubmed/36424447 http://dx.doi.org/10.1038/s41598-022-23824-3 |
Ejemplares similares
-
Comparative characterization of flavivirus production in two cell lines: Human hepatoma-derived Huh7.5.1-8 and African green monkey kidney-derived Vero
por: Saito, Kyoko, et al.
Publicado: (2020) -
Identification of Characteristic Genomic Markers in Human Hepatoma HuH-7 and Huh7.5.1-8 Cell Lines
por: Kawamoto, Masaki, et al.
Publicado: (2020) -
Direct Inhibition of SARS-CoV-2 Spike Protein by Peracetic Acid
por: Yamamoto, Yuichiro, et al.
Publicado: (2022) -
Claudin-4: A New Molecular Target for Epithelial Cancer Therapy
por: Fujiwara-Tani, Rina, et al.
Publicado: (2023) -
Efficacy and safety evaluation of claudin‐4‐targeted antitumor therapy using a human and mouse cross‐reactive monoclonal antibody
por: Hashimoto, Yosuke, et al.
Publicado: (2016)